Physician profile
Mohamed Sayed
NPI 1760847925
$14,495.75
in general payments reported to CMS, 2019-2025
8 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $15.54 · 2021: $11.59 · 2024: $66.39 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $14K · Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $13,808.63 |
| Food and Beverage | $128.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $13,820.22 | 2021-2025 | Wavelight Refractive Suite, Argos |
| Aerie Pharmaceuticals, INC. | $325.55 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $128.06 | 2019 | |
| Sun Pharmaceutical Industries INC. | $73.92 | 2019-2025 | |
| Shockwave Medical, INC | $50.00 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Allergan, INC. | $46.31 | 2019 | |
| Amneal Pharmaceuticals LLC | $29.82 | 2025 | Pemrydi Rtu |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Sayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.